This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: ETH Zurich. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: The Innovative Contributions of Anna Pratsinis
Introduction
Anna Pratsinis is a notable inventor based in Zurich, Switzerland. She has made significant contributions to the field of pharmaceutical compounds, particularly in the therapy of clostridium difficile infections. With a total of two patents to her name, her work is recognized for its potential impact on medical treatments.
Latest Patents
Anna's latest patents focus on innovative pharmaceutical compounds designed for therapeutic use. One of her inventions relates to a compound described by a general formula, wherein each X can independently be OPO, OPSO, or OSO. The compound also includes a solubility function such as a polyethylene glycol moiety. Another patent involves polysulfate derivatives or mixed polyphosphate/sulphate derivatives of six-membered cyclic polyols, aimed at treating infections.
Career Highlights
Anna Pratsinis is affiliated with ETH Zurich, a prestigious research institution known for its cutting-edge scientific advancements. Her work has garnered attention for its potential applications in the medical field, particularly in combating challenging infections.
Collaborations
Some of her notable coworkers include Bastien Castagner and Jean-Christophe Leroux, who have collaborated with her on various research projects.
Conclusion
Anna Pratsinis exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions are paving the way for new therapeutic options in the treatment of infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile